Skip to main content

Ara Dickran Metjian

Associate Professor of Medicine
Medicine, Hematology
Duke Box 3422, Duke University Medical Center, Durham, NC 27710
0547 Stead Building, 100 Trent Drive, Durham, NC 27710

Scholarly Works - Conferences


FAST4TMA: A national rapid ADAMTS13 testing initiative for TMA patients — 2025 update

Conference Blood · November 3, 2025 AbstractBackground: Immune thrombotic thrombocytopenic purpura (iTTP) is a life-threatening thrombotic microangiopathy (TMA) driven by ADAM ... Full text Cite

Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations

Conference Blood · November 13, 2019 IntroductionThe United States Thrombotic Microangiopathy (USTMA) Consortium consists of high-volume US referral centers that are committed to collaborative research in TMAs. The USTMA Immune Thrombotic Thrombocytope ... Full text Cite

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

Conference Blood · November 13, 2019 Background: Immune thrombotic thrombocytopenic purpura (iTTP) is a potentially fatal hematologic disorder characterized by thrombocytopenia, microangiopathic hemolytic anemia, and ischemic organ impairment. The incidence of iTTP is higher among Afr ... Full text Cite

The Thrombotic Microangiopathy Registry of North America

Conference Blood · December 3, 2015 AbstractThe thrombotic microangiopathies (TMAs) are rare, life-threatening thrombotic disorders of diverse etiologies. Systematic studies of TMA have been difficult to perform due to their rare occurrence, d ... Full text Cite